Pneumonic Plague Treatment
Not medical advice. This page reports what WHO, CDC, PHAC and the peer-reviewed literature state, and it carries no doses. Treatment decisions belong to a clinician.
What the official guidance says to give, when to give it, and to whom.
Updated · 9 sources, 1 with a DOI
No doses appear on this page on purpose. CDC's 2021 MMWR recommendations carry the full adult and paediatric tables.3
The 24 hour rule
123424 hours from symptom onset is the target for starting antimicrobials, not a point past which treatment fails.
Treated against untreated, pneumonic plague
4Both figures are pooled rates from one systematic review of 1946 to 2017, drawn with their confidence intervals.
First line antimicrobials
365Drug, class and route. No doses, by design.
- WHO's 2021 guideline exists to settle whether fluoroquinolones belong in first line treatment, and lists fluoroquinolone case management as one of its three revised recommendation areas. Its recommendation tables could not be retrieved, so every drug level claim here is cited to CDC or PHAC rather than to that guideline.6
- Canada's official sheet names the same set: streptomycin, gentamicin, doxycycline, ciprofloxacin, levofloxacin or moxifloxacin.5
- Alternatives include doxycycline for pneumonic and septicaemic plague, chloramphenicol, trimethoprim-sulfamethoxazole, and other agents within each class.3
Who gets post-exposure prophylaxis
3712Any one of these four is enough to qualify.
- Emergency and response workers at high risk may take prophylaxis before exposure, discontinued 48 hours after the last perceived exposure.1
Isolation and droplet precautions
31896Standard plus droplet precautions, and a clear end condition.
Sources
Every figure above links to its row here. WHO and CDC pages are the current published versions; each peer-reviewed paper carries its DOI.
-
[1]
CDC Centers for Disease Control and Prevention
Guidance for Responding to a Plague Bioterrorism Event
Accessed 2026-10-07
cdc.gov ↗ (opens in a new tab) -
[2]
WHO World Health Organization
Plague (fact sheet)
Last updated 29 September 2026 · Accessed 2026-10-07
who.int ↗ (opens in a new tab) -
[3]
CDC Nelson CA, Meaney-Delman D, Fleck-Derderian S, Cooley KM, Yu PA, Mead PS
Antimicrobial Treatment and Prophylaxis of Plague: Recommendations for Naturally Acquired Infections and Bioterrorism Response
MMWR Recommendations and Reports 2021;70(RR-3):1-27. Published 16 July 2021. The authoritative source for doses, which this site does not reproduce. · Accessed 2026-10-07
cdc.gov ↗ (opens in a new tab) -
[4]
Peer reviewed Salam AP, Rojek AM, Cai E, Raberahona M, Horby P
Deaths Associated with Pneumonic Plague, 1946-2017
Emerging Infectious Diseases 2020;26(10):2432-2434. Systematic review of 1,107 patients across 44 articles, with antimicrobial data for 108 confirmed or probable cases. · Accessed 2026-10-07
doi.org/10.3201/eid2610.191270 ↗ (opens in a new tab) -
[5]
PHAC Public Health Agency of Canada
Pathogen Safety Data Sheet: Yersinia pestis
Accessed 2026-10-07
canada.ca ↗ (opens in a new tab) -
[6]
WHO World Health Organization
WHO guidelines for plague management: revised recommendations for the use of rapid diagnostic tests, fluoroquinolones for case management and personal protective equipment for prevention of post-mortem transmission
Geneva: WHO, 27 May 2021. ISBN 978-92-4-001557-9. The recommendation tables inside the PDF could not be retrieved, so no drug-level claim on this site is cited to this guideline. · Accessed 2026-10-07
who.int ↗ (opens in a new tab) -
[7]
CDC Centers for Disease Control and Prevention
Clinical Care of Plague
Accessed 2026-10-07
cdc.gov ↗ (opens in a new tab) -
[8]
WHO World Health Organization
Plague (questions and answers)
Accessed 2026-10-07
who.int ↗ (opens in a new tab) -
[9]
ECDC European Centre for Disease Prevention and Control
Facts about plague
Accessed 2026-10-07
ecdc.europa.eu ↗ (opens in a new tab)
The symptoms, the incubation ranges and the timeline from exposure are on the symptoms page.